Off‐label use of rituximab for dermatologic conditions: A single center review

• Váldodahkkit: Emma Porter (Dahkki), Paula Finnegan (Dahkki), Amy Long (Dahkki), John F. Bourke (Dahkki), Michelle Murphy (Dahkki), Cathal O'Connor (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2024-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Rituximab (RTX) has been utilised off‐label for a variety of dermatological indications beyond pemphigus vulgaris. Efficacy has been reported in other immunobullous disorders, inflammatory dermatoses and connective tissue diseases. Objectives To assess the off‐label use of RTX in...